Squarepoint’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,734
| Closed | -$49K | – | 2842 |
|
|
2021
Q4 | $49K | Sell |
2,734
-878
| -24% | -$15.7K | ﹤0.01% | 2414 |
|
|
2021
Q3 | $134K | Sell |
3,612
-2,991
| -45% | -$111K | ﹤0.01% | 1947 |
|
|
2021
Q2 | $393K | Buy |
+6,603
| New | +$393K | ﹤0.01% | 1775 |
|
|
2021
Q1 | – | Sell |
-9,650
| Closed | -$584K | – | 3064 |
|
|
2020
Q4 | $584K | Buy |
9,650
+6,307
| +189% | +$382K | ﹤0.01% | 1397 |
|
|
2020
Q3 | $264K | Sell |
3,343
-11,023
| -77% | -$870K | ﹤0.01% | 1765 |
|
|
2020
Q2 | $898K | Buy |
+14,366
| New | +$898K | 0.01% | 994 |
|
|
2020
Q1 | – | Sell |
-4,412
| Closed | -$534K | – | 2462 |
|
|
2019
Q4 | $534K | Buy |
4,412
+2,463
| +126% | +$298K | ﹤0.01% | 1694 |
|
|
2019
Q3 | $354K | Buy |
+1,949
| New | +$354K | ﹤0.01% | 1731 |
|
|
2018
Q4 | – | Sell |
-665
| Closed | -$218K | – | 2218 |
|
|
2018
Q3 | $218K | Buy |
665
+317
| +91% | +$104K | ﹤0.01% | 1722 |
|
|
2018
Q2 | $109K | Sell |
348
-986
| -74% | -$309K | ﹤0.01% | 1636 |
|
|
2018
Q1 | $325K | Buy |
+1,334
| New | +$325K | 0.01% | 1276 |
|
|
2017
Q4 | – | Sell |
-454
| Closed | -$120K | – | 2339 |
|
|
2017
Q3 | $120K | Buy |
+454
| New | +$120K | ﹤0.01% | 1476 |
|
|
2017
Q2 | – | Sell |
-367
| Closed | -$132K | – | 1803 |
|
|
2017
Q1 | $132K | Sell |
367
-247
| -40% | -$88.8K | ﹤0.01% | 1363 |
|
|
2016
Q4 | $177K | Buy |
614
+352
| +134% | +$101K | 0.01% | 1480 |
|
|
2016
Q3 | $89K | Buy |
+262
| New | +$89K | 0.01% | 958 |
|
|
2016
Q2 | – | Sell |
-312
| Closed | -$100K | – | 1352 |
|
|
2016
Q1 | $100K | Sell |
312
-130
| -29% | -$41.7K | 0.01% | 1070 |
|
|
2015
Q4 | $229K | Buy |
+442
| New | +$229K | 0.03% | 921 |
|